Category Archives: Advertising Industry

Sahm Adrangi Shorts Proteostasis Therapeutics

Published / by Flash

Sahm Adrangi is a sell side trader that corporate executive do not want to encounter under most, if not all, circumstances. Adrangi runs a hedge fund called Kerrisdale Capital, which manages $180 million of investor funds. Andragi has made his reputation as an activist short seller, detecting corporate irregularities, shorting the shares and then calling attention to a company’s issues by releasing a report, or sending a tweet. Adrangi earned fame, and fortune to boot, by being at the forefront of a wave of short selling that called attention to fraudulent practices of Chinese companies with United States listed securities.

Recently, Sahm Adrangi issued a negative report on shares of Proteostasis Therapeutics, explaining his decision to sell short shares in the company. Proteostasis is a biotechnical company whose product is in the clinical stage. Its main drug is PTI-428, which is intended to treat cystic fibrosis that results from genetic disorders.

Sahm Adrangi’s short thesis for this company is that the Phase Two test results of this drug are not nearly as optimistic as they seem on the surface, as the success only results from favorable comparison to placebo patients, as opposed to any improvement in the patients’ conditions. He believes that the drug is actually ineffective, and that investors misinterpreted the results of the testing. Andragi was particularly disturbed by Proteostasis Therapeutics’ decision to issue nine million additional shares shortly after the release of the Phase Two trial results.

Further, Sahm Adrangi concludes that Proteostasis Therapeutics has a track record of selectively releasing study data, emphasizing the findings that present it in a positive light, while burying data that would reflect poorly upon it. Adrangi maintains that there are other results from tests that the company has performed that are not in the public domain and, if known, would cause investors to cast doubt on PTI-428’s efficacy. Beyond the ineffectiveness of PTI-428, Sahm Adrangi argues that Proteostasis Therapeutics has little in its pipeline of future drugs that would prevent the stock price from realizing a drop of at least 70%.

https://www.crunchbase.com/person/sahm-adrangi

Why Jose Borghi is a Trendsetter in the Brazilian Ad Industry

Published / by Flash / 1 Comment on Why Jose Borghi is a Trendsetter in the Brazilian Ad Industry

Major Brazilian media outlets regard Jose Henrique Borghi as one of the most proactive, resilient and prolific executives in the advertising industry. During his ad career, he has created numerous mind-blowing ad campaigns including Mammals Parmalat. This feature film seeks to enlighten members of the public about conserving wildlife. The success of the ad helped establish Borghi and Mullen Lowe Brasil as the country’s go-to ad agency.Despite the numerous challenges that he has faced, Jose Borghi’s career progression has undeniably been inspiring. At the moment, he serves as the president and co-CEO at Mullen Lowe, a dominant ad agency in Brazil. It is almost unbelievable to imagine that Borghi never thought that he would end up working in the ad industry. He only got interested after watching a Cannes Award-winning group performing in a theater. This saw him develop an interest that has been nurtured into a lifetime ambition.

Career Beginnings

Jose is an alumnus of the Catholic University of Campinas. After graduation, he secured an editorial job at Standard Ogilvy. He served the firm for a total of six years, which were highly successful. His readiness to learn and down to earth personality has gone a long way in defining his career. Jose corporate star shone brighter after joining DM9/DDB in 1994. He also worked for Leo Burnett where he was appointed CEO. During this stint, he created a fascinating ad for Fiat, which was named ad of the year in 2001.

Mullen Lowe Brasil

After realizing that a huge niche existed in the market, Borghi co-founded BorghiErh alongside Erh Ray. The startup was highly successful since it mainly targeted the market segments that had previously been ignored. To sustain this success, Borghi merged the company with Mullen & Partners to form Mullen Lowe Brasil. The firm brings together more than 90 agencies operating in 65 countries.